Indexed in

License and use

Citations

Cited 191 times in

Cited 134 times in

Cited 90 times in

Cited 187 times in

Altmetrics

Grant support

This study was supported by the Deutsche Krebshilfe (70-3173-Tr3) through the Network project Molecular Mechanisms in Malignant Lymphomas (from 2003 to 2011); the KinderKrebsInitiative Buchholz/Holm-Seppensen (W. K., R. S.); the International Cancer Genome Consortium MMML-Seq Project funded by the Federal Ministry of Education and Research in Germany within the Program for Medical Genome Research (01KU1002A to 01KU1002J); a fellowship from the Alexander von Humboldt Foundation and the Subprograma Juan de la Cierva Ministerio de Ciencia e Innovacion (JCI-2011-10232) (I. S.); a grant from the Basque Government (Ayuda del programa de perfeccionamiento postdoctoral en el extranjero del Departamento de Educacion, Universidades e Investigacion) (I.M.-G.); a Christoph-Schubert-Award of the KinderKrebsInitiative Buchholz/Holm-Seppensen (R.W.); and Dr Werner Jackstadt Stiftung through a Junior Excellence Research Group (J.R.).

Analysis of institutional authors

Share

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

Publicated to:Blood. 123 (8): 1187-1198 - 2014-02-20 123(8), DOI: 10.1182/blood-2013-06-507996

Authors: Salaverria, Itziar; Martin-Guerrero, Idoia; Wagener, Rabea; Kreuz, Markus; Kohler, Christian W; Richter, Julia; Pienkowska-Grela, Barbara; Adam, Patrick; Burkhardt, Birgit; Claviez, Alexander; Damm-Welk, Christine; Drexler, Hans G; Hummel, Michael; Jaffe, Elaine S; Kueppers, Ralf; Lefebvre, Christine; Lisfeld, Jasmin; Loeffler, Markus; Macleod, Roderick A F; Nagel, Inga; Oschlies, Ilske; Rosolowski, Maciej; Russell, Robert B; Rymkiewicz, Grzegorz; Schindler, Detlev; Schlesner, Matthias; Scholtysik, Rene; Schwaenen, Carsten; Spang, Rainer; Szczepanowski, Monika; Truemper, Lorenz; Vater, Inga; Wessendorf, Swen; Siebert, Reiner

Affiliations

Abstract

The genetic hallmark of Burkitt lymphoma (BL) is the t(8;14)(q24;q32) and its variants leading to activation of the MYC oncogene. It is a matter of debate whether true BL without MYC translocation exists. Here, we identified 59 lymphomas concordantly called BL by 2 gene expression classifiers among 753 B-cell lymphomas. Only 2 (3%) of these 59 molecular BL lacked a MYC translocation, which both shared a peculiar pattern of chromosome 11q aberration characterized by interstitial gains including 11q23.2-q23.3 and telomeric losses of 11q24.1-qter. We extended our analysis to 17 MYC-negative high-grade B-cell lymphomas with a similar 11q aberration and showed this aberration to be recurrently associated with morphologic and clinical features of BL. The minimal region of gain was defined by high-level amplifications in 11q23.3 and associated with overexpression of genes including PAFAH1B2 on a transcriptional and protein level. The recurrent region of loss contained a focal homozygous deletion in 11q24.2-q24.3 including the ETS1 gene, which was shown to be mutated in 4 of 16 investigated cases. These findings indicate the existence of a molecularly distinct subset of B-cell lymphomas reminiscent of BL, which is characterized by deregulation of genes in 11q.

Keywords